Study launched to evaluate the effectiveness of CorPath robotic assistance in performing balloon angioplasty for symptomatic peripheral arterial disease WALTHAM, MA, February 24, 2015 – Corindus ...

The first-in-human clinical study of the CorPath 200 System performed at the Corbic Research Institute, Envigado, Colombia, was conducted on eight patients to evaluate the safety and technical ...

Data demonstrates safety and efficacy of robotic-assisted percutaneous coronary interventions, while enhancing control and radiation protection for interventional cardiologists “This study has the ...

The FDA has granted clearance for the CorPath 200 System, a robotic system that assists heart surgeons in restoring blood flow to blocked coronary arteries. Corindus Vascular Robotics, a Natick, MA ...

NATICK, Mass. - Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that data and acute results from its CorPath PRECISE Trial will be presented during a ...

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, announced today that the U.S. Food and Drug Administration has ...

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today its CorPath® ...

Renowned medical journal publishes the successful clinical results of remote PCI procedures using CorPath® GRX Robotic System technology To improve patient outcomes and broaden access to high-level ...

Please provide your email address to receive an email when new articles are posted on . The concept of robotic-assisted PCI has been successfully implemented since 2011, allowing for precise ...

Shares of Corindus Vascular Robotics (NYSEMKT: CVRS), a robotic surgery company focused on vascular disease, fell 22% as of 3:39 p.m. EDT on Thursday after fourth-quarter results were released. Here's ...

Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France Corindus Vascular Robotics, Inc. ("Corindus" or the "Company") (NYSE American: CVRS), a leading developer of ...